329

Compound name
Bosutinib
Alt Name
SKI606
SKI-606
SKI 606
Compound Image
Bosutinib.png
SMILES
CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC
MW
530.45
Brutto
C26H29Cl2N5O3
InChI
InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)
InChI Key
UBPYILGKFZZVDX-UHFFFAOYSA-N
Approval Jurisdiction
2012 FDA, 2013 EMA
Approved for clinical use
Chronic Myelogenous Leukemia
CAS
380843-75-4
PubChem CID
5328940
Action
src, Bcr-Ab1, PDGFR
Approved Drug List
1
Patent
<a href="http://www.wipo.int/patentscope/search/en/result.jsf?query=ALLNUM%3AWO2013024144">WO2013024144</a>
Commercial Vendor
Pfizer